Skip to main content

Announcement of EGM Results

ALMATY, Kazakhstan, June 12, 2026 (GLOBE NEWSWIRE) — Joint Stock Company Kaspi.kz (Nasdaq: KSPI) announces that the following resolutions were duly passed at its Extraordinary General Meeting on 11 June 2026: 1. To approve the agenda of the Extraordinary General Meeting of Shareholders of JSC Kaspi.kz: 1)   Approval of the agenda;2)   Payment of dividends on common shares of JSC Kaspi.kz and approval of the amount of dividend per common share;3)   Determination of the number and the term of powers and election of members of JSC Kaspi.kz’s Counting commission. 2. To approve dividends to be paid within the period set by law: 1)   dividend amount of KZT 850 (eight hundred and fifty tenge) per common share of JSC Kaspi.kz;2)   dividend is paid for period 1Q 2026;3)   commencement date of dividend payments: 11 June 2026;4)   the list...

Continue reading

The Summer Sports Spectacle Begins – LEPAS Invites You to Embrace Refined Living

WUHU, China, June 12, 2026 (GLOBE NEWSWIRE) — In June 2026, Chery Group’s premium new energy brand LEPAS is accelerating its global deliveries in full swing. The brand embeds that pre-match composure into every detail of our Leopard Aesthetics and Elegant Technology – so every ride carries the confidence of a champion walking onto the pitch. The whistle is about to blow, and the world is buzzing with mounting excitement. Players have completed their final preparations—refining focus through rigorous training, embracing ritual-like calm, and steadying their minds as the big moment approaches. The closer the game, the calmer the rhythm. This is precisely what LEPAS embodies in its Year of Global Delivery: as the world heats up, elegance stays cool. Mastering Strength, Steering with EleganceFootball is not only about winning,...

Continue reading

Autolus Therapeutics Receives Prix Galien UK Award

LONDON and GAITHERSBURG, Md., June 12, 2026 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced that the Galien Foundation has presented the Company with the 2026 Prix Galien UK Award for Best Biotechnology Product. Winners of the prestigious Prix Galien awards are selected by a UK Awards Committee, which comprises 12 experts in the field who are leaders in UK healthcare.  “We are honored to receive this recognition from Prix Galien UK. Autolus was founded, in collaboration with University College London, to translate pioneering scientific research into new treatment options for patients in need. As a clinician, it is tremendously rewarding to see this vision become...

Continue reading

CAPITAL INCREASE – Publication of the new denominator in accordance with Article 15 of the Law of 2 May 2007

Following the capital increase of €15 million (including the share premium) through an accelerated book building process (ABB) on 10 June 2026, 311,203 new shares are being issued today (12 June 2026). In accordance with Article 15 of the Law of 2 May 2007 on the disclosure of major shareholdings (‘Transparency Law’), Ascencio SA is publishing the following information:the new share capital amounts to €41,443,128.00; the total number of shares with a voting right at the annual general meeting of shareholders becomes 6,907,188 (the denominator); the newly issued shares entitle the holders to the full amount of profit generated as from 1 October 2025 and to the same dividend as the other shares; the total number of voting rights is 6,907,188; there are no other shares or rights conferring voting rights, nor are there any non-voting  shares....

Continue reading

TGS Prediktor Delivers PowerView™ Plant SCADA for Scatec’s Grootfontein Solar Power Project, South Africa

OSLO, Norway (12 June 2026) – TGS, through its Prediktor division, will deliver its PowerView™ Plant SCADA solution for Scatec’s Grootfontein solar power project in South Africa, supporting reliable operations and centralized monitoring across three large-scale photovoltaic plants.Located near Ceres and Touws River in the Western Cape, the Grootfontein development consists of three solar plants with a combined capacity of 225 MWAC (273 MWp) connected to the national grid operated by Eskom. As part of the project, Prediktor PowerView™ enables real-time monitoring, control and performance management across the entire facility. The platform integrates operational data from plant infrastructure, including inverters, trackers, substations, weather stations and metering systems, to provide a unified operational view. The system...

Continue reading

Veteran Capital Corp. Terminates Letter of Intent for Qualifying Transaction with Powerhive

CALGARY, Alberta, June 11, 2026 (GLOBE NEWSWIRE) — Veteran Capital Corp. (“Veteran“) (TSXV: VCC.P), a Capital Pool Company listed on the TSX Venture Exchange (the “Exchange”), announces that it has terminated its letter of intent with Powerhive, Inc. (“Powerhive“) for its proposed Qualifying Transaction as a result of Powerhive’s failure to complete its required financing and/or enter into a binding definitive agreement within the timeframes set out in the letter of intent, despite repeated extensions. Additional Information Veteran has applied for Exchange approval to lift the halt on our shares. Once approved, the TSX Venture Exchange will issue a bulletin setting forth the timing of the resumption of trading. Veteran intends to continue its search for a qualified transaction with an alternative...

Continue reading

Nova Minerals Announces NYSE American Listing Approval

Anchorage, Alaska, June 11, 2026 (GLOBE NEWSWIRE) — Nova Minerals Corp (“Nova Minerals” or the “Company”) today announced that its common stock and warrants have been approved for listing on the NYSE American stock exchange. Trading is expected to begin on or about June 17, 2026, at market open under the symbols “NVA” for its common stock and “NVAWS” for its warrants. Please note that the ticker symbol for the listed warrants has been slightly modified from that previously disclosed in order to comply with the requirements of NYSE American. Nova Minerals CEO, Mr Christopher Gerteisen, commented: “Listing our common stock and our warrants on the NYSE American represents an important milestone in the Company’s development of the Estelle Gold and Critical Minerals project towards U.S. domestic production of Gold and Antimony”. Head...

Continue reading

Skyworks Announces Results of Early Participation in Exchange Offers and Consent Solicitations for Qorvo’s Senior Notes due 2029 and 2031

IRVINE, Calif., June 11, 2026 (GLOBE NEWSWIRE) — Skyworks Solutions, Inc. (Nasdaq: SWKS) (“Skyworks”), a leading developer, manufacturer and provider of analog and mixed-signal semiconductors and solutions for numerous applications, today announced that, in connection with its previously announced offers to holders of Qorvo Notes (as defined herein) to exchange (the “Exchange Offers”) any and all outstanding 4.375% Senior Notes due 2029 (the “2029 Qorvo Notes”) and any and all outstanding 3.375% Senior Notes due 2031 (the “2031 Qorvo Notes” and, together with the 2029 Qorvo Notes, the “Qorvo Notes”) issued by Qorvo, Inc. (“Qorvo”) as set forth in the table below for, (1) with respect to the 2029 Qorvo Notes, up to $850,000,000 aggregate principal amount of new 4.375% Senior Notes due 2029 (the “New 2029 Skyworks Notes”) issued...

Continue reading

Questor Postpones Its Annual General Meeting and Announces Statement of Claim Filed by Former President and CEO

CALGARY, Alberta, June 11, 2026 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor” or the “Company”) (TSX-V: QST) announces the postponement of its Annual General Meeting (the “Meeting”), originally scheduled for June 15, 2026 at 1:00 p.m. MDT. This decision has been made as a result of a delay in the Meeting materials being filed on SEDAR+ due to an inadvertent error by the third-party service provider engaged by Questor to conduct such filings, and concerns that some shareholders have not received the Meeting materials mailed to them.   The Meeting is also being postponed due to legal proceedings initiated on June 8, 2026 by the Company’s former President and CEO, Audrey Mascarenhas, whose employment was terminated effective April 20, 2026. Ms. Mascarenhas has filed a statement of claim at the Court...

Continue reading

Lophos Holdings Inc. Provides Corporate Update and Strategic Outlook

VANCOUVER, British Columbia, June 11, 2026 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (“Lophos” or the “Company“) (CSE: MESC), a Canadian bioscience company focused on regulated plant-based and controlled substance opportunities, today provides a corporate update regarding recent leadership and governance changes, the status of its Controlled Substances Dealer’s Licence (“CSDL“), the Company’s ongoing efforts to address the cease trade order affecting its securities, and its strategic priorities moving forward. Leadership and Board Changes Effective May 6, 2026, Joshua Herman was appointed Chief Executive Officer of the Company and joined the Board of Directors (the “Board“). Brad Cotton and Cory Harris were also appointed to the Board. The Company welcomes Mr. Herman, Mr....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.